Oura’s IPO draws four times demand with $2.2 billion target - Bloomberg

Oura Inc., a health and fitness ring manufacturer, has received orders for four times the shares in its IPO, targeting $2.2 billion. The company and selling shareholders are offering 50 million shares priced between $40 and $44 each. Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co., and Jefferies are lead underwriters.

Original reporting
Published Sep 25, 2026, 7:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 7:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefIPO
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$OURA
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

Med
01

Why it matters

The 4× oversubscription signals strong investor interest, likely supporting a premium pricing and a robust debut.

02

Market read

First‑report of Oura's IPO demand provides actionable insight for IPO‑focused traders and sector investors.

03

What to watch

Potential regulatory scrutiny of health data and competition from larger wearables players.

Relevance 7/10Novelty 7/10Timing: order book closes Monday afternoon

Background

Oura Inc., a health‑fitness ring maker, is preparing a U.S. IPO targeting up to $2.2 billion.

Market effects

Strong demand may boost health‑tech and wearables sector sentiment.

U.S. IPO market sees renewed investor appetite, supporting broader equity inflows.

High‑profile IPO could attract foreign capital and set a benchmark for upcoming tech listings.

Counterpoint

Demand could be overstated; pricing may be adjusted downward if market conditions shift.

Key entities

  • Oura Inc.

    Health and fitness ring manufacturer planning IPO.

  • Goldman Sachs

    Lead underwriter for Oura's IPO.

Related articles

HighAI 8/10

Oura IPO Oversubscribed 4x, Seeks $2.2B

Oura, a health and fitness ring maker, is offering 50 million shares at $40-$44, aiming to raise up to $2.2B. The IPO is oversubscribed 4x, with pricing expected Sept. 29. The company's market cap could reach $14.1B. Goldman Sachs, Morgan Stanley, and others are leading the deal. Oura plans to list on the Nasdaq.

$OURAHighAI 8/10

Nelson Advisors: Eli Lilly’s Strategic Stake in Oura and the Convergence of GLP-1 Therapeutics, Continuous Biometric Monitoring

Eli Lilly plans to invest up to $100M in Oura's IPO, joining Dragoneer's $300M commitment. Oura, a digital health platform, aims to raise up to $2.2B via Nasdaq listing. The company reported $1.42B revenue, $60.8M net income for the trailing year. Eli Lilly sees Oura as a strategic partner for GLP-1 therapeutic monitoring and patient retention.

$OURAHighAI 8/10

Oura’s IPO Puts AI-Powered Healthcare on the Ticker

Oura, an AI-powered healthcare company, reported 74% revenue growth to $1.21 billion in nine months. Membership revenue rose 121% to $240.5 million. Eli Lilly may invest $100 million. Oura's IPO targets a $15.62 billion valuation and will trade on Nasdaq under OURA.

$OURAHighAI 9/10

US IPO Week Ahead: Smart ring maker Oura and AI power play Accelevation headline a $2.8 billion week

Oura (OURA) plans a $2.1 billion IPO at a $15.0 billion market cap, with 73% of shares sold by existing shareholders. Accelevation (ACCV) aims to raise $660 million at a $4.9 billion valuation. Oura sells smart rings for health tracking, while Accelevation provides AI and data center infrastructure. Both IPOs are set for a $2.8 billion week.

$OURAHighAI 8/10

Oura IPO said to draw four times demand as orders near close

Oura Inc.'s IPO has drawn strong interest, with orders reaching four times the shares available, aiming to raise up to $2.2B. The company and shareholders are offering 50M shares priced between $40-$44 each. At the top of the range, Oura's market value could reach $14.1B. The IPO is set to price on Sept. 29 and trade on Nasdaq under ticker OURA.

$OURAHighAI 8/10

Oura Targets Up to $15.6 Billion Valuation in IPO, Surpassing Prada and Lululemon

Oura, a health-tracking smart ring company, aims for a $15.6 billion valuation in its U.S. IPO, selling 50 million shares at $40-$44 each, potentially raising $2.2 billion. The offering is set to price Sept. 29, with shares trading on Nasdaq under OURA. Oura reported $1.21 billion in revenue for the nine months ended June 30, up 74% year over year, with 5 million paid members.